International Stem Cell (ISCO) Operating Leases (2019 - 2025)
International Stem Cell's Operating Leases was $103,000 in Q3 2025, down 49.3% from $203,000 a year earlier and down 49.5% from the prior quarter.
Powered by 
Analysis
International Stem Cell (ISCO) Operating Leases (2019 - 2025) Analysis & Trends
At the end of FY2024, Operating Leases at International Stem Cell came in at $115,000, down 74.2% from FY2023.
- Operating Leases has now declined for three consecutive years, with a five-year compound annual growth rate of -30.7% (FY2019 to FY2024).
- In earlier years, Operating Leases was $445,000 in FY2023 (-38.2%), $720,000 in FY2022 (-24.2%), $950,000 in FY2021 (+12.4%) and $845,000 in FY2020 (+17.7%).
- The Q3 2025 figure marks the lowest quarterly Operating Leases in data going back to Q1 2019.
- Compared with a year earlier, Operating Leases has declined for 12 straight quarters, with an average decline of 45.5% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q3 2022 (growth of 21.1%); the worst was Q4 2024 (a decline of 74.2%).
- Per Business Quant data, ISCO's Operating Leases in the three quarters before Q3 2025 was $204,000 (Q2 2025), $302,000 (Q1 2025) and $115,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | International Stem Cell | 2.08 Mn | -1.89 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 204,000.00 |
| Mar 31, 2025 | 302,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Mar 31, 2024 | 367,000.00 |
| Dec 31, 2023 | 445,000.00 |
| Sep 30, 2023 | 518,000.00 |
| Jun 30, 2023 | 588,000.00 |
| Mar 31, 2023 | 656,000.00 |
| Dec 31, 2022 | 720,000.00 |
| Sep 30, 2022 | 781,000.00 |
| Jun 30, 2022 | 840,000.00 |
| Mar 31, 2022 | 896,000.00 |
| Dec 31, 2021 | 950,000.00 |
| Sep 30, 2021 | 645,000.00 |
| Jun 30, 2021 | 714,000.00 |
| Mar 31, 2021 | 781,000.00 |
| Dec 31, 2020 | 845,000.00 |
API Access
International Stem Cell Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();